Genome & Company (KOSDAQ: 314130)
South Korea
· Delayed Price · Currency is KRW
2,915.00
-15.00 (-0.51%)
Nov 15, 2024, 9:00 AM KST
Genome & Company Market Cap
Genome & Company has a market cap or net worth of 90.43 billion as of November 18, 2024. Its market cap has decreased by -45.61% in one year.
Market Cap
90.43B
Enterprise Value
87.83B
Revenue
23.92B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,915.00
Market Cap Chart
Since December 26, 2018, Genome & Company's market cap has increased from 71.88B to 90.43B, an increase of 25.82%. That is a compound annual growth rate of 3.97%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition